Patent classifications
A61L15/54
IN VIVO DETECTION OF SURGICAL MATERIALS
Provided herein are surgical materials detectable by multiple imaging modalities, including magnetic resonance imaging (MRI) and computerized tomography (CT). In some embodiments, provided herein are surgical materials comprising bismuth nanoparticles and/or iron oxide nanoparticles.
IN VIVO DETECTION OF SURGICAL MATERIALS
Provided herein are surgical materials detectable by multiple imaging modalities, including magnetic resonance imaging (MRI) and computerized tomography (CT). In some embodiments, provided herein are surgical materials comprising bismuth nanoparticles and/or iron oxide nanoparticles.
MEDICAL DRESSING MATERIAL HAVING CHITOSAN FABRIC SPONGE STRUCTURE AND METHOD OF MANUFACTURING SAME
A medical dressing material having a chitosan fabric sponge structure according to the present disclosure has a structure in which chitosan fibers derived from a chitosan fabric are located on a porous structure formed using freeze-drying. Therefore, the medical dressing material has an excellent hemostatic effect and exudate-absorbing ability while exhibiting a strong tensile force, is convenient to use, and is capable of being molded into various forms so as to be widely used for wounds by an edged thing, scalds, pressure ulcers, diabetes-related foot disorders, or various surgical areas in various body tissue parts such as the spine, brain, eye, ear, nose, and cervix.
MEDICAL DRESSING MATERIAL HAVING CHITOSAN FABRIC SPONGE STRUCTURE AND METHOD OF MANUFACTURING SAME
A medical dressing material having a chitosan fabric sponge structure according to the present disclosure has a structure in which chitosan fibers derived from a chitosan fabric are located on a porous structure formed using freeze-drying. Therefore, the medical dressing material has an excellent hemostatic effect and exudate-absorbing ability while exhibiting a strong tensile force, is convenient to use, and is capable of being molded into various forms so as to be widely used for wounds by an edged thing, scalds, pressure ulcers, diabetes-related foot disorders, or various surgical areas in various body tissue parts such as the spine, brain, eye, ear, nose, and cervix.
MEDICAL DEVICE, METHOD OF USING AND MAKING THE SAME
The invention is directed towards a device, method of using and making the same and more particularly to a sterile, biocompatible, fiber free, foam device configured to be used in various different uses, e.g., medical uses, make-up removal uses, and other uses.
MEDICAL DEVICE, METHOD OF USING AND MAKING THE SAME
The invention is directed towards a device, method of using and making the same and more particularly to a sterile, biocompatible, fiber free, foam device configured to be used in various different uses, e.g., medical uses, make-up removal uses, and other uses.
Permeable Superabsorbent and Process for Production Thereof
A highly permeable superabsorbent is prepared by a process comprising
polymerizing an aqueous monomer solution comprising
a) at least one ethylenically unsaturated monomer which bears acid groups and is optionally at least partly in salt form,
b) at least one crosslinker,
c) at least one initiator,
d) optionally one or more ethylenically unsaturated monomers copolymerizable with the monomers mentioned under a), and
e) optionally one or more water-soluble polymers;
drying the resulting polymer,
optionally grinding the dried polymer and sieving the ground polymer,
optionally surface postcrosslinking the dried and optionally ground and sieved polymer,
wherein, after drying, grinding or sieving, and, if surface postcrosslinking is conducted, during or after this surface postcrosslinking, x-ray-amorphous aluminum hydroxide powder is added.
Permeable Superabsorbent and Process for Production Thereof
A highly permeable superabsorbent is prepared by a process comprising
polymerizing an aqueous monomer solution comprising
a) at least one ethylenically unsaturated monomer which bears acid groups and is optionally at least partly in salt form,
b) at least one crosslinker,
c) at least one initiator,
d) optionally one or more ethylenically unsaturated monomers copolymerizable with the monomers mentioned under a), and
e) optionally one or more water-soluble polymers;
drying the resulting polymer,
optionally grinding the dried polymer and sieving the ground polymer,
optionally surface postcrosslinking the dried and optionally ground and sieved polymer,
wherein, after drying, grinding or sieving, and, if surface postcrosslinking is conducted, during or after this surface postcrosslinking, x-ray-amorphous aluminum hydroxide powder is added.
ACTIVATED FILMS HAVING LOW SOUND PRESSURE LEVELS
A film having low pressure values is provided. The film may have from about 20 wt. % to about 75 wt. % of a polyolefin component, from about 5 wt. % to about 35 wt. % of an elastomeric resin, and from about 20 wt. % to about 45 wt. % of a particle component. The film may have a basis weight of from about 5 gsm to about 25 gsm. The film may have a predicted sound pressure level over the frequency octave range of 2000 Hz-6300 Hz of less than about 43 dB.
ACTIVATED FILMS HAVING LOW SOUND PRESSURE LEVELS
A film having low pressure values is provided. The film may have from about 20 wt. % to about 75 wt. % of a polyolefin component, from about 5 wt. % to about 35 wt. % of an elastomeric resin, and from about 20 wt. % to about 45 wt. % of a particle component. The film may have a basis weight of from about 5 gsm to about 25 gsm. The film may have a predicted sound pressure level over the frequency octave range of 2000 Hz-6300 Hz of less than about 43 dB.